GSA Capital Partners »

Reneo Pharmaceuticals shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Reneo Pharmaceuticals (RPHM) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Reneo Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Reneo Pharmaceuticals held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Reneo Pharmaceuticals by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $152k 95k 1.60

More positions owned by GSA Capital Partners

Amazon (AMZN)
CRH Ord (CRH)
Remitly Global (RELY)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Aon Shs Cl A (AON)
Magnite Ord (MGNI)
Zillow Group Cl A (ZG)
UnitedHealth (UNH)
Sprott Fds Tr Uranium Miners E (URNM)
Vanguard World Fds Health Car Etf (VHT)
Sba Communications Corp Cl A (SBAC)
Calavo Growers (CVGW)
Appfolio Com Cl A (APPF)
Star Bulk Carriers Corp. Shs Par (SBLK)
Bwx Technologies (BWXT)

View all positions for GSA Capital Partners

Top funds holding Reneo Pharmaceuticals

NEA Management Company
Tang Capital Management
Carlyle
RiverVest Venture Management
Octagon Capital Advisors
BML Capital Management
Ikarian Capital
Highbridge Capital Management
Vanguard Group
Aisling Capital Management
Caption Management
Two Sigma Investments
Millennium Management
LMR Partners
GSA Capital Partners

View all funds holding Reneo Pharmaceuticals